[1]
Geschwind DH. Autism: Many genes, common pathways? Cell 2008; 135(3): 391-5.
[2]
Landa RJ. Diagnosis of autism spectrum disorders in the first 3 years of life. Nat Clin Pract Neurol 2008; 4(3): 138-47.
[3]
Fombonne E. Epidemiology of pervasive developmental disorders. Pediatr Res 2009; 65(6): 591-8.
[4]
Newschaffer CJ, Croen LA, Daniels J, et al. The epidemiology of autism spectrum disorders. Annu Rev Public Health 2007; 28: 235-58.
[5]
Müller RA. The study of autism as a distributed disorder. Ment Retard Dev Disabil Res Rev 2007; 13(1): 85-95.
[6]
Bertoglio K, Hendren RL. New developments in autism. Psychiatr Clin North Am 2009; 32(1): 1-14.
[7]
Liu H, Talalay P, Fahey JW. Biomarker-guided strategy for treatment of autism spectrum disorder (ASD). CNS Neurol Disord Drug Target 2016; 15(5): 602-13.
[8]
Ghaziuddin M, Al-Owain M. Autism spectrum disorders and inborn errors of metabolism: An update. Pediatr Neurol 2013; 49(4): 232-6.
[9]
Blau N, Hennermann JB, Langenbeck U, Lichter-Konecki U. Diagnosis, classification, and genetics of phenylketonuria and te’trahydrobiopte’rine (BH4) deficiencies. Mol Genet Metab 2011; 104: S2-9.
[10]
Moyle JJ, Fox AM, Arthur M, Bynevelt M, Burnett JR. Meta-analysis of neuropsychological symptoms of adolescents and adults with PKU. Neuropsychol Rev 2007; 17: 91-101.
[11]
Martinelli I, Tomassoni D, Moruzzi M, Traini E, Amenta F, Tayebati SK. Obesity and metabolic syndrome affect the cholinergic transmission and cognitive functions. CNS Neurol Disord Drug Targets 2017; 16(6): 664-76.
[12]
Wada O. What are trace elements? Their deficiency and excess states. J Japan Med Assoc 2004; 47: 351-8.
[14]
Manzi B, Loizzo AL, Giana G, Curatolo P. Autism and metabolic diseases. J Child Neurol 2008; 23(3): 307-14.
[15]
Williams RA, Mamotte CD, Burnett JR. Phenylketonuria: An inborn error of phenylalanine metabolism. Clin Biochem Rev 2008; 29(1): 31-41.
[16]
Baieli S, Pavone L, Meli C, Fiumara A, Coleman M. Autism and phenylketonuria. J Autism Dev Disord 2003; 33(2): 201-4.
[17]
Diamond A. Consequences of variations in genes that affect dopamine in prefrontal cortex. Cereb Cortex 2007; 17(1): 161-70.
[18]
Glushakow AV, Dennis DM, Sumners C, Seubert CN, Martynyuk AE. L-phenylalanine selectively depresses currents at glutamatergic excitatory synapses. J Neurosci Res 2003; 72: 116-24.
[19]
Moritani T, Smoker WR, Sato Y, Numaguchi Y, Westesson PL. Diffusion-weighted imaging of acute excitotoxic brain injury. AJNR Am J Neuroradiol 2005; 26: 216-28.
[20]
Kono K, Okano Y, Nakayama K, et al. Diffusion-weighted MR imaging in patients with phenylketonuria: Relationship between serum phenylalanine levels and ADC values in cerebral white matter. Radiology 2005; 236: 630-6.
[21]
Kiykim E, Zeybek CA, Zubarioglu T, et al. Inherited metabolic disorders in turkish patients with autism spectrum disorders. Autism Res 2016; 9: 217-23.
[22]
Grünert SC, Müllerleile S, De Silva L, et al. Propionic acidemia: Clinical course and outcome in 55 pediatric and adolescent patients. Orphanet J Rare Dis 2013; 8: 6.
[23]
Grünert SC, Müllerleile S, De Silva L, et al. Propionic acidemia: Neonatal versus selective metabolic screening. J Inherit Metab Dis 2012; 35: 41-9.
[24]
Grünert SC, Wendel U, Lindner M, et al. Clinical and neurocognitive outcome in symptomatic isovaleric academia. Orphanet J Rare Dis 2012; 7: 9.
[25]
Nath R. Health and disease: Role of micronutrients and trace elements. APH Publishing Corporation New Delhi 2000; p. 650.
[26]
Rossignol DA, Genuis SJ, Frye RE. Environmental toxicants and autism spectrum disorders: A systematic review. Transl Psychiatry 2014; 4e360
[27]
Cikankova T, Sigitova E, Zverova M, Fisar Z, Raboch J, Hroudova J. Mitochondrial dysfunctions in bipolar disorder: Effect of the disease and pharmacotherapy. CNS Neurol Disord Drug Targets 2017; 16(2): 176-86.
[28]
Maret W. Zinc and human disease. Met Ions Life Sci 2013; 13: 389-414.
[30]
Faber S, Zinn GM, Kern JC, Kingston HM. The plasma Zinc/ serumCu2+ ratio as a biomarker in children with autism spectrum disorders. Biomarkers 2009; 14: 171-80.
[31]
Lakshmi Priya, Geetha A. Levels of trace elements (cu2+, Zinc, magnesium and selenium) and toxic elements (lead and mercury) in the hair and nail of children with autism. Biol Trace Elem Res 2011; 142(2): 148-58.
[32]
de Magistris L, Familiari V, Pascotto A, et al. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J Pediatr Gastroenterol Nutr 2010; 51: 418-24.
[33]
Vela G, Stark P, Socha M, Sauer AK, Hagmeyer S, Grabrucker AM. Zinc in gut – brain interaction in Autism and neurological disorders. Neural Plast 2015; 2015972791
[34]
Goldstein L, Pfeiffer CC. Effects of single oral doses of trace elements on the quantitated EEG of normal subjects and chronic schizophrenics. Psychopharmacol Bull 1978; 14: 55-7.
[35]
Mitchell CL, Barnes MI, Grimes LM. Diethyldithiocarbamate and dithizone augment the toxicity of kainic acid. Brain Res 1990; 50: 327-30.
[36]
Frederickson RE, Frederickson CJ, Danscher G. In situ binding of bouton zinc reversibly disrupts performance on a spatial memory task. Behav Brain Res 1990; 38: 25-33.
[37]
Tang SM. Hair zinc and copper concentration in patients with epilepsy. Zhonghua Shen Jing Jing Shen Ke Za Zhi 1991; 24(2): 124-5.
[38]
Russo AJ, Bazin AP, Bigega R, et al. Plasma copper and zinc concentration in individuals with autism correlate with selected symptom severity. Nutr Metab Insight 2012; 5: 41-7.
[39]
Hoffer A. Children with learning and behavioral disorders. J Orthomol Psychiatry 1976; 5: 228-30.
[40]
Russo A, Robert D. Analysis of copper deficiency induces enhanced depression – like and Zinc plasma concentration and the efficacy of zinc therapy in individual with Asperger’s syndrome, pervasive developmental disorder not otherwise specified (PDD NOS) and autism. Biomark Insights 2011; 6: 127-33.
[41]
Elsheshtawy E, Tobar S, Sherra K, Atallah S, Elkasaby R. Study of some biomarkers in hair of children with autism. Middle East Current Psychiatry 2011; 18: 6-10.
[42]
Geier DA, King PG, Sykes LK, Geier MR. A comprehensive review of mercury provoked autism. Indian J Med Res 2008; 128(4): 383-411.
[43]
Jiang HX, Chen LS, Zheng JG, Han S, Tang N, Smith BR. Aluminum-induced effects on Photosystem II photochemistry in citrus leaves assessed by the chlorophyll a fluorescence transient. Tree Physiol 2008; 28(12): 1863-71.
[44]
Naeher LP, Aguilar-Villalobos M, Miller T. Blood lead survey of children, pregnant women, professional drivers, street workers, and office workers in Trujillo, Peru. Arch Environ Health 2004; 59(7): 359-62.
[45]
Mohamed FB, Zaky EA, El-Sayed AB, et al. Assessment of hair aluminum, lead, and mercury in a sample of autistic egyptian children: Environmental risk factors of heavy metals in autism. Behav Neurol 2015; 2015545674
[46]
Fang T, Aronson KJ, Campbell LM. Freshwater fish consumption relations with total hair mercury and selenium among women in Eastern China. Arch Environ Contam Toxicol 2012; 62(2): 323-32.
[47]
Geier DA, Geier MR. A prospective study of thimerosal containing Rho(D)-immune globulin administration as a risk factor for autistic disorders. J Matern Fetal Neonatal Med 2007; 20(5): 385-90.
[48]
Amaral DG, Schumann CM, Nordahl CW. Neuroanatomy of autism. Trends Neurosci 2008; 31(3): 137-45.
[49]
Hardan AY, Muddasani S, Vemulapalli M, Keshavan MS, Minshew NJ. An MRI study of increased cortical thickness in autism. Am J Psychiatry 2006; 163(7): 1290-2.
[50]
Hardan AY, Jou RJ, Keshavan MS, Varma R, Minshew NJ. Increased frontal cortical folding in autism: A preliminary MRI study. Psychiatry Res 2004; 131(3): 263-8.
[51]
Kosinovsky B, Hermon S, Yoran-Hegesh R, et al. The yield of laboratory investigations in children with infantile autism. J Neural Transm 2005; 112: 587-96.
[52]
Kwon CH, Luikart BW, Powell CM, et al. Pten regulates neuronal arborization and social interaction in mice. Neuron 2006; 50: 377-88.
[54]
Chez MG, Chang M, Krasne V, Coughlan C, Kominsky M, Schwartz A. Frequency of epileptiform EEG abnormalities in a sequential screening of autistic patients with no known clinical epilepsy from 1996 to 2005. Epilepsy Behav 2006; 8(1): 267-71.
[55]
Reinhold JA, Molloy CA, Manning-Courtney P. Electroencephalogram abnormalities in children with autism spectrum disorders. J Neurosci Nurs 2005; 37(3): 136-8.
[56]
Gubbay SS, Lobascher M, Kingerlee P. A neurologic appraisal of autistic children: Results of a western Australian survey. Dev Med Child Neurol 1997; 12: 422-9.
[57]
Ošlejšková H, Dusek L, Makovska A, Rector I. Epilepsia, epileptiform abnormalities, non-right-handedness, hypotonia and severe decreased IQ are associated with language impairment in autism. Epileptic Disord 2007; 9(1): S9-18.
[58]
Amiet C, Gourfinkel-An I, Laurent C, et al. Epilepsy in simplex autism pedigrees is much lower than the rate in multiplex autism pedigrees. Biol Psychiatry 2013; 74(3): e3-4.
